死亡与濒死焦虑量表在晚期癌症患者中跨文化调试及应用
发布时间：2019-06-09 19:32
【摘要】：目的引入死亡与濒死焦虑量表(Death and Dying Distress Scale,DADDS)通过翻译、综合、回译、专家内容效度评价及信效度检验等对量表进行跨文化调试,形成中文版DADDS量表,并在晚期癌症患者中进行初步应用。方法经量表原作者Lo.C同意后,根据跨文化调适过程的指南,对量表进行正向翻译、综合、回译、专家评议、预调查,形成中文版量表,第一阶段预试验采用便利抽样法在安徽省某三甲肿瘤专科医院获取目的抽样抽取30名晚期癌症患者进行中文版DADDS量表的预实验,形成中文版DADDS量表临床施测版本,并与2016年6月-2016年11月,采用中文版DADDS临床施测版本对134例晚期癌症患者进行信效度检验,采用项目分析法对量表条目进行评价,采用专家法来评价内容效度、主成分因子分析和平行分析法评价结构效度。第二阶段,采用中文版DADDS在108例晚期癌症患者群体中初步应用。结果(1)中文版量表各条目CVI值为0.875~1.000之间,S-CVI/Ave为0.983;(2)极端组法评估条目鉴别度显示,各条目高低两组得分均有统计学差异(P0.05),表明条目具有较好的鉴别度;(3)结构效度应用探索性因子分析,结果显示特征值大于1的因子数目为2个,累积方差贡献率为72.331%;经最大正交旋转后因子载荷矩阵发现条目4、6、7、8、9、11出现因子横跨的现象。经平行分析结果显示因子数为1时,实际观察数据特征值大于随机数据平均特征值,所以因子数为1时为最佳量表因子个数。本研究采用固定单因子提取,当原量表的因子个数为1时,特征值为9.704,方差贡献率64.694%,条目的载荷量0.731-0.857。(4)内部一致性信度克朗巴赫α系数为0.960,分半信度Spearman-Brown系数为0.898,重测信度0.810。(5)晚期癌症患者死亡焦虑总体得分为40.68±16.74(0-69)。中文版DADDS量表得分最高的前两位分别是:条目8、条目9。(6)单因素分析结果显示,不同性别、不同婚姻状况及有无宗教信仰的晚期癌症患者死亡焦虑水平差异有统计学意义,P0.05。将单因素分析中对死亡焦虑总分有影响的3个变量作为自变量,进行多元逐步线性回归分析。自变量性别、婚姻状况、宗教信仰进入回归模型,对因变量死亡焦虑水平有显著性影响,P值分别为0.002、0.027和0.035。结论中文版DADDS量表信度、效度较好,适用于我国晚期癌症患者死亡焦虑的评估。
[Abstract]:Objective to introduce the death and near death anxiety scale (Death and Dying Distress Scale,DADDS) into the Chinese version of DADDS scale by means of translation, synthesis, back translation, expert content validity evaluation and reliability and validity test. And to carry on the preliminary application in the advanced cancer patient. Methods with the consent of Lo.C, the original author of the scale, according to the guide of cross-cultural adjustment process, the scale was translated positively, synthesized, translated back, reviewed by experts, pre-investigated, and the Chinese version of the scale was formed. In the first stage of the pre-trial, 30 patients with advanced cancer were selected by convenient sampling method in a third Class Cancer Hospital in Anhui Province to form the clinical version of the Chinese version of the DADDS scale. From June 2016 to November 2016, the reliability and validity of 134patients with advanced cancer were tested by Chinese version of DADDS clinical test, the items of the scale were evaluated by item analysis, and the content validity was evaluated by expert method. Principal component factor analysis and parallel analysis were used to evaluate the structural validity. In the second stage, the Chinese version of DADDS was used in 108 patients with advanced cancer. Results (1) the CVI value of each item of the Chinese version of the scale was 0.875 鈮，
本文编号：2495836
[Abstract]:Objective to introduce the death and near death anxiety scale (Death and Dying Distress Scale,DADDS) into the Chinese version of DADDS scale by means of translation, synthesis, back translation, expert content validity evaluation and reliability and validity test. And to carry on the preliminary application in the advanced cancer patient. Methods with the consent of Lo.C, the original author of the scale, according to the guide of cross-cultural adjustment process, the scale was translated positively, synthesized, translated back, reviewed by experts, pre-investigated, and the Chinese version of the scale was formed. In the first stage of the pre-trial, 30 patients with advanced cancer were selected by convenient sampling method in a third Class Cancer Hospital in Anhui Province to form the clinical version of the Chinese version of the DADDS scale. From June 2016 to November 2016, the reliability and validity of 134patients with advanced cancer were tested by Chinese version of DADDS clinical test, the items of the scale were evaluated by item analysis, and the content validity was evaluated by expert method. Principal component factor analysis and parallel analysis were used to evaluate the structural validity. In the second stage, the Chinese version of DADDS was used in 108 patients with advanced cancer. Results (1) the CVI value of each item of the Chinese version of the scale was 0.875 鈮，
本文编号：2495836
本文链接：https://www.wllwen.com/shoufeilunwen/mpalunwen/2495836.html
最近更新
教材专著
